Quebec biotech startup nets record-breaking seed stage investment

    Quebec biotech startup nets record-breaking seed stage investment

Recent $21M investment in ILKOS THERAPEUTICS is 17 times larger than average VC seed deal since 2013 By the Canadian Venture Capital and Private Equity Association The Fonds de solidarité

Read Full Article

Shermaine Tilley joins Immunovaccine’s board

Shermaine Tilley, a managing partner at CTI Life Sciences Fund, has been nominated to serve on the board of Immunovaccine Inc, a Halifax-based developer of cancer immunotherapies and infectious disease

Read Full Article

Venture Capital Breakout Report: Life Sciences

    Venture Capital Breakout Report: Life Sciences

With life sciences driving a considerable amount of the recent surge in venture capital, we thought we’d take a closer look at this sector to understand what’s behind all the

Read Full Article

CTI Life Sciences invests in SutroVax Series A

    CTI Life Sciences invests in SutroVax Series A

SutroVax, a biopharmaceutical vaccine company, has announced the completion of a USD$22 million Series A financing. The Series A financing was led

Read Full Article

XTuit Pharmaceuticals Closes $22 Million Series A Financing to Advance Novel Microenvironmental Modulators for Cancers and Fibrotic Disorders

    XTuit Pharmaceuticals Closes $22 Million Series A Financing to Advance Novel Microenvironmental Modulators for Cancers and Fibrotic Disorders

CTI Life Sciences Fund joins Polaris Partners and New Enterprise Associates in a $22 million Series A financing for XTuit

Read Full Article

Fonds de solidarité invests $4M in Zymeworks

    Fonds de solidarité invests $4M in Zymeworks

Fonds de solidarité FTQ has invested $4 million in common shares of Zymeworks Inc., a biotherapeutics company focused on the

Read Full Article

Zymeworks and Lilly expand strategic licensing and collaboration agreement

    Zymeworks and Lilly expand strategic licensing and collaboration agreement

Zymeworks Inc. and Eli Lilly and Company (NYSE: LLY) has expanded their existing licensing and collaboration agreement. Originally announced in

Read Full Article

SIGN UP FOR DAILY DEALS AND NEWS UPDATE

CVCA Events

CVCA on Twitter